Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3201)
All Articles published online
|
Aug 28, 2007 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tangkijvanich P, Thong-ngam D, Mahachai V, Theamboonlers A, Poovorawan Y. Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma. World J Gastroenterol 2007; 13(32): 4345-4349 [PMID: 17708609 DOI: 10.3748/wjg.v13.i32.4345] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i32/4345.htm |
| Number | Citing Articles |
| 1 |
Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Sun Young Park, Joo Han Park, Jae Keun Kim, Hee Jung Wang, Jae Youn Cheong, Sung Won Cho. Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. Cytokine 2015; 73(2): 245 doi: 10.1016/j.cyto.2015.02.027
|
| 2 |
Emmanuel Somm, François R. Jornayvaz. Interleukin-18 in metabolism: From mice physiology to human diseases. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.971745
|
| 3 |
Hongwen Zhu, Youpei Lin, Dayun Lu, Shisheng Wang, Yuejia Liu, Liangqing Dong, Qian Meng, Jing Gao, Yuqiu Wang, Nixue Song, Yuying Suo, Li Ding, Pei Wang, Bing Zhang, Daming Gao, Jia Fan, Qiang Gao, Hu Zhou. Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma. National Science Review 2023; 10(8) doi: 10.1093/nsr/nwad167
|
| 4 |
Theodore H. Welling, Sherry Fu, Shanshan Wan, Weiping Zou, Jorge A. Marrero. Elevated Serum IL-8 Is Associated with the Presence of Hepatocellular Carcinoma and Independently Predicts Survival. Cancer Investigation 2012; 30(10): 689 doi: 10.3109/07357907.2012.732161
|
| 5 |
Zakaria Y. Mohran, Fatma A. Ali-Eldin, Hala A. Abdel Aal. Serum interleukin-18: Does it have a role in the diagnosis of hepatitis C virus related hepatocellular carcinoma?. Arab Journal of Gastroenterology 2011; 12(1): 29 doi: 10.1016/j.ajg.2010.11.002
|
| 6 |
A.C. Teixeira, C.T. Mendes-Junior, L.A. Marano, N.H.S. Deghaide, M. Secaf, J. Elias-Junior, V. Muglia, E.A. Donadi, A.L.C. Martinelli. Alleles and genotypes of polymorphisms of IL-18, TNF-α and IFN-γ are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil. Human Immunology 2013; 74(8): 1024 doi: 10.1016/j.humimm.2013.04.029
|
| 7 |
Jingui Bao, Yu Lu, Yan Deng, Chengzhi Rong, Yanqiong Liu, Xiuli Huang, Liuying Song, Shan Li, Xue Qin. Association between IL-18 polymorphisms, serum levels, and HBV-related hepatocellular carcinoma in a Chinese population: a retrospective case–control study. Cancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0223-z
|
| 8 |
Chintana Chirathaworn, Yong Poovorawan. Targeted Cancer Immune Therapy. 2009; : 19 doi: 10.1007/978-1-4419-0170-5_2
|
| 9 |
Pengyuan Yang, Geoffrey J. Markowitz, Xiao-Fan Wang. The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma. National Science Review 2014; 1(3): 396 doi: 10.1093/nsr/nwu038
|
| 10 |
Ayman Abdelghaffar Eldesoky, Nancy Abdel Fattah Ahmed, Hosam Eldeen Zaghloul, Amr Ahmed Abdel Aziz. Interleukin-18 polymorphism as a diagnostic tumor marker for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00062-8
|
| 11 |
Xiaoli Ju, Zhilong Yang, Heng Zhang, Qiang Wang. Role of pyroptosis in cancer cells and clinical applications. Biochimie 2021; 185: 78 doi: 10.1016/j.biochi.2021.03.007
|
| 12 |
Duangporn Werawatganon, Sittikorn Linlawan, Kessarin Thanapirom, Kanjana Somanawat, Naruemon Klaikeaw, Rungsun Rerknimitr, Prasong Siriviriyakul. Aloe vera attenuated liver injury in mice with acetaminophen-induced hepatitis. BMC Complementary and Alternative Medicine 2014; 14(1) doi: 10.1186/1472-6882-14-229
|
| 13 |
Chun-I Wang, Pei-Ming Chu, Yi-Li Chen, Yang-Hsiang Lin, Cheng-Yi Chen. Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC. International Journal of Molecular Sciences 2021; 22(24): 13627 doi: 10.3390/ijms222413627
|
| 14 |
Wannipha Tongsima, Sissades Tongsima, Prasit Palittapongarnpim, Philip E. Bourne. Outlook on Thailand's Genomics and Computational Biology Research and Development. PLoS Computational Biology 2008; 4(7): e1000115 doi: 10.1371/journal.pcbi.1000115
|
| 15 |
Geoffrey J. Markowitz, Pengyuan Yang, Jing Fu, Gregory A. Michelotti, Rui Chen, Jianhua Sui, Bin Yang, Wen-Hao Qin, Zheng Zhang, Fu-Sheng Wang, Anna Mae Diehl, Qi-Jing Li, Hongyang Wang, Xiao-Fan Wang. Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes. Cancer Research 2016; 76(8): 2394 doi: 10.1158/0008-5472.CAN-15-1548
|
| 16 |
Kevin J. Baker, Aileen Houston, Elizabeth Brint. IL-1 Family Members in Cancer; Two Sides to Every Story. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01197
|
| 17 |
Masamichi Kimura, Koji Nishikawa, Jun Imamura, Kiminori Kimura. Stem Cell Growth Factor-β as a Predictive Biomarker of Response to Chemotherapy and Prognosis in Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Study. Cancers 2024; 16(2): 320 doi: 10.3390/cancers16020320
|
| 18 |
Dongjie Wang, Bitian Zhang, Xiaolin Liu, Lea Ling-Yu Kan, Ping-Chung Leung, Chun-Kwok Wong. Agree to disagree: The contradiction between IL-18 and IL-37 reveals shared targets in cancer. Pharmacological Research 2024; 200: 107072 doi: 10.1016/j.phrs.2024.107072
|
| 19 |
Yijuan Zhang, Yunbo Li, Yifan Ma, Shuhui Liu, Yinglong She, Peng Zhao, Mingzhen Jing, Tao Han, Chao Yan, Zhenghui Wu, Jinrong Gao, Linbai Ye. Dual effects of interleukin-18: inhibiting hepatitis B virus replication in HepG2.2.15 cells and promoting hepatoma cells metastasis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011; 301(3): G565 doi: 10.1152/ajpgi.00058.2011
|
| 20 |
Eleonora Timperi, Vincenzo Barnaba. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1263: 25 doi: 10.1007/978-3-030-44518-8_3
|
| 21 |
Feiyue Chen, Bingxin Li, Wanyan Li, Wenbin Chen, Yunmao Huang, Yunbo Tian, Baohe Yang, Mingfeng Yuan, Danning Xu, Nan Cao. Polysaccharide of Atractylodes macrocephala Koidz alleviate lipopolysaccharide-stimulated liver inflammation injury of goslings through miR-223/NLRP3 axis. Poultry Science 2023; 102(1): 102285 doi: 10.1016/j.psj.2022.102285
|
| 22 |
Abhilasha Srivastava, Harshita Sharma, Simran Khanna, Tejasvini Sadhu Balasundaram, Shibasish Chowdhury, Rajdeep Chowdhury, Sudeshna Mukherjee. Interleukin-6 Induced Proliferation Is Attenuated by Transforming Growth Factor-β-Induced Signaling in Human Hepatocellular Carcinoma Cells. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.811941
|
| 23 |
Arseniy E. Yuzhalin, Anton G. Kutikhin. Interleukins in Cancer Biology. 2015; : 17 doi: 10.1016/B978-0-12-801121-8.00002-6
|
| 24 |
Serena Janho dit Hreich, Paul Hofman, Valérie Vouret-Craviari. The Role of IL-18 in P2RX7-Mediated Antitumor Immunity. International Journal of Molecular Sciences 2023; 24(11): 9235 doi: 10.3390/ijms24119235
|
| 25 |
Sha Fu, Rong-rong Zhou, Ning Li, Yan Huang, Xue-Gong Fan. Hepatitis B virus X protein in liver tumor microenvironment. Tumor Biology 2016; 37(12): 15371 doi: 10.1007/s13277-016-5406-2
|
| 26 |
Qi Shao, Ning Liu, Guo-Fu Li, Qian-Cheng Meng, Jia-Hao Yao, Ning Wang. IL-18 expression in clinical human pituitary adenoma. Technology and Health Care 2021; 30(1): 11 doi: 10.3233/THC-191967
|
| 27 |
Aihong Wang, Yin Wang, Chenxiang Du, Huilun Yang, Zhengping Wang, Canhui Jin, Michael R. Hamblin. Pyroptosis and the tumor immune microenvironment: A new battlefield in ovarian cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(2): 189058 doi: 10.1016/j.bbcan.2023.189058
|
| 28 |
Manohar Babu Kuppala, Sunayana Begum Syed, Srinivas Bandaru, Sreedevi Varre, Jyothy Akka, Hema Prasad Mundulru. Immunotherapeutic Approach for Better Management of Cancer - Role of IL-18. Asian Pacific Journal of Cancer Prevention 2012; 13(11): 5353 doi: 10.7314/APJCP.2012.13.11.5353
|
| 29 |
Tzu-An Liu, Yee-Jee Jan, Bor-Sheng Ko, Yi-Ju Wu, Yi-Jhu Lu, Shu-Man Liang, Chia-Chia Liu, Shyh-Chang Chen, John Wang, Song-Kun Shyue, Jun-Yang Liou. Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma. Oncotarget 2015; 6(36): 38967 doi: 10.18632/oncotarget.5734
|
| 30 |
Hu Yang, Yang Xuefeng, Xiao Jianhua. Systematic review of the roles of interleukins in hepatocellular carcinoma. Clinica Chimica Acta 2020; 506: 33 doi: 10.1016/j.cca.2020.03.001
|
| 31 |
凌风 熊. Inflammatory Microenvironment: Problems of Liver Tumor Cells and Liver Cancer Stem Cells. Advances in Clinical Medicine 2021; 11(10): 4591 doi: 10.12677/ACM.2021.1110675
|
| 32 |
Puneeta Tandon, Guadalupe Garcia‐Tsao. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver International 2009; 29(4): 502 doi: 10.1111/j.1478-3231.2008.01957.x
|
| 33 |
Zhen Yao, Minyan Zhao, Guangyu Gao, Jiawen Yang, Zhenzhen Wang, Yulong Liu. Prognostic Role of IL-18 in Various Human Cancers and Radiation Injuries: A Meta-Analysis. Dose-Response 2020; 18(2): 155932582093136 doi: 10.1177/1559325820931360
|
| 34 |
Caecilia H. C. Sukowati, Riccardo Patti, Devis Pascut, Rusdina B. Ladju, Paola Tarchi, Nunzia Zanotta, Manola Comar, Claudio Tiribelli, Lory S. Crocè. Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/6435482
|
| 35 |
Shadi Chamseddine, Yehia I. Mohamed, Sunyoung S. Lee, James C. Yao, Zishuo Ian Hu, Hop S. Tran Cao, Lianchun Xiao, Ryan Sun, Jeffrey S. Morris, Rikita I. Hatia, Manal Hassan, Dan G. Duda, Maria Diab, Amr Mohamed, Ahmed Nassar, Saumil Datar, Hesham M. Amin, Ahmed Omar Kaseb. Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma. Oncology 2023; 101(11): 730 doi: 10.1159/000531870
|
| 36 |
Jeong Won Jang, Byong Sun Oh, Jung Hyun Kwon, Chan Ran You, Kyu Won Chung, Chul Seung Kay, Hyun Suk Jung. Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma. Cytokine 2012; 60(3): 686 doi: 10.1016/j.cyto.2012.07.017
|
| 37 |
PHANTHAKARN TIT-OON, DARANEE CHOKCHAICHAMNANKIT, AMNART KHONGMANEE, PHANEE SAWANGAREETRAKUL, JISNUSON SVASTI, CHANTRAGAN SRISOMSAP. Comparative secretome analysis of cholangiocarcinoma cell line in three-dimensional culture. International Journal of Oncology 2014; 45(5): 2108 doi: 10.3892/ijo.2014.2636
|
| 38 |
J. Randolph Hecht, Sara Lonardi, Johanna Bendell, Hao-Wen Sim, Teresa Macarulla, Charles D. Lopez, Eric Van Cutsem, Andres J. Muñoz Martin, Joon Oh Park, Richard Greil, Hong Wang, Rebecca R. Hozak, Ivelina Gueorguieva, Yong Lin, Sujata Rao, Baek-Yeol Ryoo. Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA). Journal of Clinical Oncology 2021; 39(10): 1108 doi: 10.1200/JCO.20.02232
|
| 39 |
Seo Young Park, Jiyou Han, Jong Bin Kim, Man-Gil Yang, Yoon Jun Kim, Hee-Joung Lim, Su Yeon An, Jong-Hoon Kim. Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma. European Journal of Cancer 2014; 50(2): 341 doi: 10.1016/j.ejca.2013.09.021
|
| 40 |
Mohamad Adham Salkeni, Aung Naing. Interleukin-10 in cancer immunotherapy: from bench to bedside. Trends in Cancer 2023; 9(9): 716 doi: 10.1016/j.trecan.2023.05.003
|
| 41 |
Sirish Dharmapuri, Umut Özbek, Hiren Jethra, Tomi Jun, Thomas U Marron, Anwaar Saeed, Yi-Hsiang Huang, Mahvish Muzaffar, Matthias Pinter, Lorenz Balcar, Claudia Fulgenzi, Suneetha Amara, Arndt Weinmann, Nicola Personeni, Bernhard Scheiner, Tiziana Pressiani, Musharraf Navaid, Bertram Bengsch, Sonal Paul, Uqba Khan, Dominik Bettinger, Naoshi Nishida, Yehia Ibrahim Mohamed, Arndt Vogel, Anuhya Gampa, James Korolewicz, Antonella Cammarota, Ahmed Kaseb, Peter R Galle, Anjana Pillai, Ying-Hong Wang, Alessio Cortellini, Masatoshi Kudo, Antonio D’Alessio, Lorenza Rimassa, David James Pinato, Celina Ang. Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2023; 15(11): 1900-1912 doi: 10.4251/wjgo.v15.i11.1900
Abstract(193) |
Core Tip(180) |
Full Article(HTML)(1182)
|
Full Article with Cover (PDF)-842K(28)
|
Full Article (Word)-197K(13)
|
Audio-1935K(0)
|
Peer-Review Report-254K(21)
|
Answering Reviewers-107K(18)
|
Full Article (PDF)-551K(60)
|
Full Article (XML)-183K(16)
|
Times Cited (2)
|
Total Visits (2728)
|
Open
|
| 42 |
Hendrik W. van Deventer, Joseph E. Burgents, Qing Ping Wu, Rita-Marie T. Woodford, W. June Brickey, Irving C. Allen, Erin McElvania-Tekippe, Jonathan S. Serody, Jenny P.-Y. Ting. The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells. Cancer Research 2010; 70(24): 10161 doi: 10.1158/0008-5472.CAN-10-1921
|
| 43 |
Giuseppe Palma, Antonio Barbieri, Sabrina Bimonte, Marco Palla, Silvia Zappavigna, Michele Caraglia, Paolo A. Ascierto, Gennaro Ciliberto, Claudio Arra. Interleukin 18: Friend or foe in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2013; 1836(2): 296 doi: 10.1016/j.bbcan.2013.09.001
|
| 44 |
Siqi Liu, Lanlan Yang, Shengnan Jia, Rui Zhao, Zhenjing Jin. Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinoma. International Immunopharmacology 2021; 100: 108161 doi: 10.1016/j.intimp.2021.108161
|
| 45 |
Colleen S. Curran, Elad Sharon. PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma. Seminars in Oncology 2017; 44(6): 428 doi: 10.1053/j.seminoncol.2017.12.001
|